RaySearch Laboratories AB (publ) announces the launch of RayStation®* 12A, the latest version of the company’s advanced treatment planning system.
STOCKHOLM, June 29, 2022 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* 12A, the latest version of the company's advanced treatment planning system. Version 12A includes innovative new features in addition to several general enhancements. Deep learning segmentation for all users Brachy planning for Elekta afterloaders Other highlights of RayStation 12A include robust evaluation on multiple images, new and much faster electron Monte Carlo dose engine, and improvements for CyberKnife planning. Johan Löf, founder and CEO, RaySearch, says: "Making deep learning segmentation available to all users will substantially reduce time for contouring of organs and is a good example of our ambition to automate the treatment planning process." CONTACT: Johan Löf, founder and CEO, RaySearch Laboratories AB (publ) Björn Hårdemark, interim CFO, RaySearch Laboratories AB (publ) This information was brought to you by Cision http://news.cision.com The following files are available for download:
SOURCE RaySearch Laboratories |
||||||
Company Codes: Bloomberg:RAYB@SS, ISIN:SE0000135485, RICS:RAYB.ST, Stockholm:RAY-B |